“Increasing patient volumes will drive the demand for follow-up services, placing a potentially unmanageable burden on cardiology service providers,” projects Dr. Carsten Stoepel from the Lukas ...

In March 2014, the New York Court of Appeals issued a 4-3 decision in Biotronik, A.G. v. Conor Medsys. Ireland, 22 N.Y.3d 799 (2014), that according to the dissent and considerable commentary ...

Today we conclude our series on a Federal Anti-Kickback enforcement action which was announced last week, involving the Oregon based medical device manufacturer Biotronik Inc. (Biotronik). Today, I ...

NICE, France, – BIOTRONIK, a leading manufacturer of cardiovascular medical technology, is presenting its new heart stimulator at the Cardiostim 2014 electrophysiology and cardiology congress. With a ...

Biotronik announced 2 new studies last week that are slated to examine the company’s CRT-D device and BioMonitor implanted cardiac monitor. A 277-patient BioContinue clinical trial will examine the ...

We have not had a This Day in History opening for the FCPA Compliance and Ethics Blog for some time. So not only is one long overdue but a shipwreck which occurred some 66 years ago makes a great ...

Biotronik has a CE mark in hand for its new Eluna pacemakers, made with MRI-compatible technology and other advances designed to help them stand out in an already-crowded, stagnant market. The new ...

BIOTRONIK, a globally recognized leader in medical technology, has chosen Flex Databases to support and enhance the management of its clinical trial operations. The company will adopt Flex Databases’ ...

Longtime Mayo Clinic cardiologist joins Biotronik as CMO David Hayes, MD, who practiced cardiology and held leadership roles at Mayo Clinic for more than 40 years, has left the Rochester, Minn.-based ...